Advertisement
Cerus Corporation

Cerus Corporation (CERS) Stock Overview

Explore Cerus Corporation’s financial performance, market position, analyst ratings, and future outlook.

CERSNASDAQ
HealthcareMedical - Devices
$2.56
$0.03(1.16%)
U.S. Market opens in 64h 34m
Advertisement

Cerus Corporation (CERS)

Meyka AI Score

Z

Key Financials

Market Cap512.9M
P/E Ratio-52.04
EPS (TTM)$-0.05
ROE-0.15%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

CERS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cerus Corporation (CERS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.74, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -52.04 and a market capitalization of 512.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.16%
5-Day Change
-7.25%
1-Month Change
0.39%
3-Month Change
50.59%
6-Month Change
17.43%
Year-to-Date (YTD) Change
24.27%
1-Year Change
86.86%
3-Year Change
0.79%
5-Year Change
-56.54%
All-Time (Max) Change
-78.89%

Contact Information

925 288 6000
1220 Concord Avenue, Concord, CA, 94520

Company Facts

6,140 Employees
IPO DateJan 31, 1997
CountryUS
Actively Trading

Frequently Asked Questions